GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

46.55 -0.48 (-1.02%)

Official Closing Price Updated: 4:10 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

45 46 Next >

GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons

June 21, 2023

From GSK plc

Via Business Wire

GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis B

June 20, 2023

From GSK plc

Via Business Wire

Sanofi Stock Is Trading Higher Today - Here's Why ↗

June 20, 2023

Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to...

Via Benzinga

Peering Into GSK's Recent Short Interest ↗

May 19, 2023

Via Benzinga

3 Undervalued Consumer Stocks to Buy in June ↗

June 20, 2023

These undervalued consumer stocks to buy could attract investor attention as possible hedges against inflation and a recession.

Via InvestorPlace

3 Gene Testing Stocks to Buy Before They Take Off ↗

June 17, 2023

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Via InvestorPlace

UK Gives Nod To Roomba Maker IRobot-Amazon Deal, Micron Plans To Invest In China Despite Restrictions, Baidu Secures Regulatory Nod for Self-Driving Taxi: Today's Top Stories ↗

June 16, 2023

Benzinga

Via Benzinga

2 Top Healthcare Stocks to Buy Right Now ↗

June 16, 2023

The demand for healthcare sector goods and services is both predictable and growing.

Via The Motley Fool

Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M ↗

June 16, 2023

Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that

Via Benzinga

FDA Pushes Review Time For GSK's Blood Cancer Therapy Added Via Sierra Oncology Acquisition ↗

June 16, 2023

The FDA has extended the review period for GSK plc's (NYSE:

Via Benzinga

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

June 08, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making...

Via FinancialNewsMedia

ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected: Today's Top Stories ↗

June 07, 2023

Benzinga Cable Giant CNN Chairman, CEO Chris Licht Moves Out

Via Benzinga

GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults ↗

June 07, 2023

The European Commission has approved GSK plc's (NYSE:

Via Benzinga

June 2023 Stock Considerations ↗

June 07, 2023

With a new trading month already in full swing it is time, once again, to highlight some of my potential stock purchases.

Via Talk Markets

SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency: Today's Top Stories ↗

June 06, 2023

Benzinga

Via Benzinga

FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades ↗

June 06, 2023

Via Benzinga

GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US

June 01, 2023

From GSK plc

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 25, 2023

Via Benzinga

WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake ↗

May 19, 2023

An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the

Via Benzinga

BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition

May 16, 2023

From BELLUS Health Inc.

Via Business Wire

Could Latecomer Moderna Match Big Pharma Rivals in RSV? ↗

May 16, 2023

RSV is a key part of Moderna's respiratory vaccine business.

Via The Motley Fool

A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court ↗

May 15, 2023

The U.S.

Via Benzinga

3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗

May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

Via InvestorPlace

GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo? ↗

May 12, 2023

GSK plc (NYSE: GSK) presented preliminary results from the phase 3 trial of imm

Via Benzinga

Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody ↗

May 12, 2023

The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have

Via Benzinga

GSK Trims Stake On Consumer Business Spin Off, Raises £804M ↗

May 12, 2023

GSK Plc (NYSE: GSK) sold 240 mi

Via Benzinga

Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns ↗

May 12, 2023

The monoclonal antibody shot significantly reduced the risk of hospitalization in babies.

Via Investor's Business Daily

SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress

May 11, 2023

From SpringWorks Therapeutics, Inc.

Via GlobeNewswire

The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer ↗

May 11, 2023

RSV could be the next big battleground for big pharma -- but it could soon become crowded.

Via The Motley Fool

Dividend Income Update April 2023 ↗

May 11, 2023

With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated.

Via Talk Markets

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.